Guirguis Amira, Corkery John Martin, Stair Jacqueline Leslie, Kirton Stewart Brian, Zloh Mire, Schifano Fabrizio
School of Life and Medical Sciences, Department of Pharmacy, Pharmacology & Postgraduate Medicine, University of Hertfordshire, Hatfield, UK.
Psychopharmaology, Drug Misuse, & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield, UK.
Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2598.
Cathinones are one of the most popular categories of new psychoactive substances (NPS) consumed. Cathinones have different pharmacological activities and receptor selectivity for monoamine transporters based on their chemical structures. They are incorporated into NPS mixtures and used with other NPS or 'traditional' drugs. Cathinone use represents significant health risks to individuals and is a public health burden.
Evidence of poly-NPS use with cathinones, seizure information, and literature analyses results on NPS mixtures was systematically gathered from online database sources, including Google Scholar, Scopus, Bluelight, and Drugs-Forum.
Results highlight the prevalence of NPS with low purity, incorporation of cathinones into NPS mixtures since 2008, and multiple members of the cathinone family being present in individual UK-seized samples. Cathinones were identified as adulterants in NPS marketed as being pure NPS, drugs of abuse, branded products, herbal blends, and products labelled "not for human consumption." Toxicity resulting from cathinone mixtures is unpredictable because key attributes remain largely unknown. Symptoms of intoxication include neuro-psychological, psychiatric, and metabolic symptoms. Proposed treatment includes holistic approaches involving psychosocial, psychiatric and pharmacological interventions.
Raising awareness of NPS, education, and training of health care professionals are paramount in reducing harms related to cathinone use.
卡西酮是消费最广泛的新型精神活性物质(NPS)类别之一。卡西酮基于其化学结构对单胺转运体具有不同的药理活性和受体选择性。它们被掺入NPS混合物中,并与其他NPS或“传统”药物一起使用。使用卡西酮对个人构成重大健康风险,是一项公共卫生负担。
从在线数据库来源(包括谷歌学术、Scopus、蓝光和药物论坛)系统收集了卡西酮与多种NPS联合使用的证据、癫痫发作信息以及关于NPS混合物的文献分析结果。
结果突出了低纯度NPS的流行情况、自2008年以来卡西酮被掺入NPS混合物的情况,以及在英国查获的单个样本中存在卡西酮家族的多个成员。卡西酮被鉴定为在市场上作为纯NPS、滥用药物、品牌产品、草药混合物以及标有“非供人类食用”的产品中的掺杂物。卡西酮混合物导致的毒性是不可预测的,因为关键特性在很大程度上仍然未知。中毒症状包括神经心理、精神和代谢症状。建议的治疗方法包括涉及心理社会、精神和药物干预的整体方法。
提高对NPS的认识、对医护人员进行教育和培训对于减少与卡西酮使用相关的危害至关重要。